Skip to content
ZenSynergy Institute Education · Wellness · Community
Join a gathering

Resources

A small, serious shelf

External sources we trust enough to send you to — plus a glossary for words that get used loosely. We do not control these sites, and listing them is not an endorsement of every claim they make.

Glossary

Set

The inner conditions you bring to an experience: expectation, mood, intention, sleep, and personal history. Not a vision board — a risk variable.

Setting

The outer conditions: place, people, legality, medical backup, sound, and whether you can leave. Beauty is not the same as governance.

Integration

The ordinary work after an intense experience: rest, language, relationships, and not making irreversible decisions in a glow or a crash.

Informed consent

A process, not a signature. You can explain benefits, harms, unknowns, legal status, and your plan if things go poorly — in your own words.

Harm reduction

Public-health practices that reduce preventable injury. It is not permission, not panic, and not a substitute for licensed care.

Unblinding

When participants or therapists can tell who received the active drug. Common in psychedelic trials and a reason to read effect sizes carefully.

Service center

In some U.S. states, a licensed setting for legal psilocybin services under state law. Not a federal medical approval.

Facilitator

A person who holds a session. The word is unregulated in most places. Ask for training, license, insurance, and a medical plan — not a title.

Therapeutic duality

ZenSynergy’s educational name for taking preparation and nervous-system state as seriously as the session itself. A framework, not an approved product.

Moral injury

Distress from events that violate a person’s sense of right — common in military and first-responder communities, and not identical to PTSD.

Aftercare

Scheduled contact and practical support after a session. If it is only “reach out if you need,” it is not aftercare.

Screening

A process that can say no. Cardiac risk, psychosis history, medicines, and pregnancy are typical domains. Screening that never excludes is marketing.

No terms match that search.

Research and clinical literacy

  • MAPS / Lykos public materials

    Primary source for MDMA-assisted therapy research history. Read methods and critiques, not only advocacy.

  • ClinicalTrials.gov

    Search psilocybin, MDMA, ibogaine, ketamine. Look at actual status, inclusion criteria, and adverse-event reporting.

  • PubMed

    For the paper behind a headline. Start with the abstract, then the limitations paragraph.

  • Cochrane Library

    When a systematic review exists, it is often more honest than a single glowing trial.

Policy and legal landscape (not legal advice)

  • Oregon Psilocybin Services

    State-regulated adult-use psilocybin services. Read the rules, not a retreat brochure’s summary of them.

  • Colorado Natural Medicine

    Another evolving state framework. Confirm current status before assuming access.

  • FDA psychedelic guidance

    Search the FDA site for psychedelic clinical-trial guidance. Useful for understanding what “approved treatment” would actually require.

Crisis and ordinary care

  • 988 Suicide & Crisis Lifeline

    Call or text 988 in the United States. Veterans: 988, then press 1, or text 838255.

  • FindTreatment.gov

    A starting map for licensed behavioral-health care, including substance use.

  • VA Mental Health

    For veterans already in or entering VA care. Complementary to, not replaced by, this institute.

Harm-reduction education

  • Drug Policy Alliance — harm reduction

    General harm-reduction frame. We do not endorse every policy position; we do endorse literacy.

  • DanceSafe

    Adulteration and testing education. Relevant because unknown substance is a leading preventable harm.